⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

SB
SBI MFSBI Contra Fund - Growth - Direct PlanDirect · Growth
₹393.34 as on 29 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricSBSBI Contra Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMCSBI MFHDFC MF
CategoryEquity - Contra FundEquity - Sectoral Fund - Pharma & Health Care
NAV₹393.34 (29 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★
BenchmarkBSE 500 - TRIBSE Health Care - TRI
Fund ManagerDinesh BalachandranNikhil Mathur
Inception01 Jan 201304 Oct 2023
Returns
1Y-9.28%22.64%
3Y10.36%30.41%
5Y13.52%—
Since Inception14.69%29.15%
Risk
12.4514.07
0.880.59
0.311.59
1.7321.67
0.583.48
-11.18%-9.23%
Costs
Expense Ratio0.88%1.03%
Exit Load0.25% on or before 30D, 0.10% after 30D but before 90D, Nil after 90D1% on or before 30D, Nil after 30D
Min SIP₹500₹100
Min Lumpsum₹5,000₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
SBI MF99%
HDFC MF99%
1.4%

Only 1.4% of holdings by weight are common between SBI MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Common holdingSBI MFHDFC MF
Aster DM Quality Care Ltd.1.42%3.56%

Category context: Equity vs Equity. Open the full Screener →